6533b7dcfe1ef96bd1271ea7

RESEARCH PRODUCT

Time-in-range for monitoring glucose control: Is it time for a change?

subject

description

The HbA1c value has been the gold standard for evaluating glucose control for decades. However, it has limitations such as the lack of information on glycemic variability or the risk of hypoglycemia. The increasing use of continuous glucose monitoring has provided patients and healthcare professionals with a range of useful metrics for the management of diabetes. Among them, Time in Range (TIR) is a simple and intuitive metric that gives information regarding the quality of glucose control. It is defined as the time spent in an individual's target glucose range. TIR is strongly correlated with HbA1c, and it has been linked to the risk of developing microvascular and macrovascular complications. The International Consensus on Time in Range has recently set targets for different diabetes populations. For the majority of people with type 1 or type 2 diabetes, a TIR (70-180 mg/dL or 3.9-10.0 mmol/L) of70%, a time below range (TBR)70 mg/dL (3.9 mmol/L) of4% and a TBR54 (3.0 mmol/L) of1% are recommended. In this review, we address the latest evidence for the use of TIR as an essential parameter in the management of diabetes.